title: Further evidence that prostate-specific antigen screening reduces prostate cancer mortality.
authors.affiliation: Affiliations of authors: Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (MJS, JJ); Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA (MJS); Department of Pathology, University of Illinois at Chicago, Chicago, IL (PG).
authors.forename: Meir J
authors.initials: MJ
authors.lastname: Stampfer
authors.forename: Jaquelyn L
authors.initials: JL
authors.lastname: Jahn
authors.forename: Peter H
authors.initials: PH
authors.lastname: Gann
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000401:mortality*
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen